European Companies Search Engine
17 EU fundings (total €7,271,320): 101045949 - XVR011 Phase 2 - Exevir's XVR011, a Best in Class Nanobody-Based Biology That Broadly Neutralizes Sars-COV-1 and Sars-COV-2 … BdlYear 2021 Financial Transparency System
Text
Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW, Ghent, Belgium
This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW, Ghent, Belgium.
The visualizations for "Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW - 17 EU fundings (total €7,271,320): 101045949 - XVR011 Phase 2 - Exevir's XVR011, a Best in Class Nanobody-Based Biology That Broadly Neutralizes Sars-COV-1 and Sars-COV-2 …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.